enGene Holdings Inc. (Nasdaq: ENGN), a clinical-stage genetic medicines company, has announced an agreement to sell 6,758,311 of its common shares at a price of $8.90 per share. This financing round is expected to close on October 29, 2024, pending…
Maze Therapeutics, a clinical-stage biopharmaceutical company focused on leveraging human genetics to create innovative small molecule precision medicines for common diseases, has announced promising results from the Phase 1 clinical trial of its drug candidate MZE829 in healthy volunteers. MZE829…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced updates on its kidney disease pipeline, which includes treatments for IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). These updates highlight the transformative potential of Vertex’s investigational therapies and include…
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company specializing in targeted therapies for RAS-driven cancers, has announced promising early data on RMC-9805, a selective inhibitor for the RAS(ON) G12D mutation. The preliminary safety and antitumor results for RMC-9805 were…
D.A. Davidson has announced its role as the exclusive sell-side financial advisor to Allivet, Inc., an online pet pharmacy specializing in medications, supplements, and various pet products, regarding its upcoming sale to Tractor Supply Company (NASDAQ: TSCO). Founded in 1992…
GenSight Biologics Reports €3.4 Million Cash Position as of September 30, 2024, and Business Update GenSight Biologics (“GenSight” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company dedicated to developing innovative gene therapies for retinal neurodegenerative diseases…
Launch of Access to Health Initiative Announced at World Stroke Congress The World Stroke Organization (WSO) President, Dr. Sheila Martins, officially launched the Access to Health initiative at the annual World Stroke Congress in Abu Dhabi. This collaboration with Merz…
eyonis™ LCS Achieves Key Milestones in REALITY Study; Upcoming Webcast Scheduled Key Highlights: Operational and Financial Overview:Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced that its Board of Directors approved the consolidated IFRS financial statements for H1 2024 on October 23,…
Shields Health Solutions (Shields), a leading specialty pharmacy accelerator and a Walgreens-owned company, has expanded its partnership with Sutter Health, one of the largest nonprofit health systems in the U.S., to increase patient access to specialty medications for chronic, rare,…
YourHealth Launches YourHealth Life: A Revolutionary Subscription-Based Health Management Tool YourHealth, a leader in consumer-controlled health applications, is thrilled to announce the launch of YourHealth Life, an innovative suite of subscription-based features designed to significantly enhance the consumer health management…
Valor Compounding Pharmacy Invites New Partnerships with Medical Practices and Hospital Systems Valor Compounding Pharmacy, a prominent provider of compounded medications, is excited to announce its initiative to form new partnerships with medical practices and health systems. This effort aims…
New Leadership Team Set to Drive Growth and Innovation in Precision Medicine MedGenome, a leader in multiomics and precision medicine, has announced the appointment of Felix Olale, M.D., Ph.D., as President and Chief Executive Officer, and Jennifer Rose as Executive…